Study links recession to 1,000 suicides

LONDON (Reuters) – A painful British economic recession, rising unemployment and biting austerity measures may have driven more than 1,000 people in England to commit suicide, according to a scientific study published on Wednesday. The study, a so-called time-trend analysis which compared the actual number of suicides with those expected if pre-recession trends had continued, reflects findings elsewhere in Europe where suicides are also on the rise. …

Government to review cosmetic surgery industry

A nurse displays a cleaned defective silicone gel breast implant, manufactured by French company Poly Implant Prothese after being removed from a patient in NiceLONDON (Reuters) – The Department of Health has launched a review of the cosmetic surgery industry, which could lead to tighter restrictions on the way companies operate and market their services in the wake of the PIP breast implant scandal. The Department of Health said on Wednesday that Bruce Keogh, medical director of the National Health Service, would lead a team that will gather evidence and make recommendations to the government by March. …

GSK sells Australian drugs to Aspen for $270 mln

A GlaxoSmithKline logo is seen outside one of its buildings in west London, ahead of company resultsJOHANNESBURG/LONDON (Reuters) – GlaxoSmithKline advanced its clear-out of non-core drugs on Wednesday with a deal to sell 25 older brands marketed in Australia to South Africa's Aspen Pharmacare for 172 million pounds. Andrew Witty, chief executive of Britain's biggest drugmaker, said last month during quarterly results that he was looking for further ways to simplify the GSK business, following previous divestments in consumer health. The old Australian brands being bought by Aspen include herpes treatment Valtrex, epilepsy drug Lamictal and the antibiotic Amoxil. …

UK to review cosmetic surgery industry

Defective silicone gel breast implants, manufactured by French company Poly Implant Prothese, is seen near surgical instruments after being removed from a patient in NiceLONDON (Reuters) – Britain has launched a review of the cosmetic surgery industry, which could lead to tighter restrictions on the way companies operate and market their services in the wake of the PIP breast implant scandal. The Department of Health said on Wednesday that Bruce Keogh, medical director of the National Health Service, would lead a team that will gather evidence and make recommendations to the government by March. …

1 57 58 59 60 61 106